Cholesterol metabolism in the brain

Current Opinion in Lipidology

Volumn 12, Issue 2, 2001, Pages 105-112

  Dietschy, John M ^a   Turley, Stephen D ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; HUMAN; MYELINATION; NERVE DEGENERATION; NERVE MEMBRANE; NERVE REGENERATION; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; BRAIN; CARRIER PROTEINS; CENTRAL NERVOUS SYSTEM DISEASES; CHOLESTEROL; HUMANS; STEROLS;

EID: 0035083555     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200104000-00003     Document Type: Review

References (60)

1. The antiatherogenic role of high-density lipoprotein cholesterol
2. In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport
3. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions
4. Sterols and gene expression: Control of affluence
5. Nuclear receptor regulation of cholesterol and bile acid metabolism
6. LXR, a nuclear receptor that defines a distinct retinoid response pathway
7. Tissue distribution and quantification of the expression of PPARs and LXRa in humans: No alterations in adipose tissue of obese and NIDDM patients
8. Localization and ontogeny of the orphan receptor OR-1 in the rat brain
9. A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily
10. Ubiquitous receptor: A receptor that modulates gene activation by retinoic acid and thyroid hormone receptors
11. OR-1, a member of the nuclear receptor superfamily that interacts with the 9-cis-retinoic acid receptor
12. Identification of a nuclear receptor that is activated by Farnesol metabolites
13. Isolation of proteins that interact specifically with retinoid X receptor: Two novel orphan receptors
14. Identification of the DNA binding specificity and potential target genes for the farnesoid X-activated receptor
15. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway
16. An oxysterol signalling pathway mediated by the nuclear receptor LXRα
17. Identification of nuclear receptors for bile acids
18. Bile acids: Natural ligands for orphan nuclear receptors
19. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
20. Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile
21. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha
22. CPF: An orphan nuclear receptor that regulates liver-specific expression of the human cholesterol 7alpha-hydroxylase gene
23. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors
24. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
25. Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription
26. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis
27. α-Fetoprotein transcription factor Is required for the expression of sterol 12α-hydroxylase, the specific enzyme for cholic acid synthesis. Potential role in the bile acid-mediated regulation of gene transcription
28. Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer
29. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells
30. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
31. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers
32. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids
33. Interaction of free apoliproteins with macrophages: Formation of high density lipoproteins and reduction of cellular cholesterol
34. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
35. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
36. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux
37. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
38. Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis
39. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
40. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1
41. Scavenger receptor-BI inhibits ATP-binding cassette transporter 1-mediated cholesterol efflux in macrophages
42. Sterol-dependent transactivation of the human ABC1 promoter by liver X receptor/retinoid X receptor
43. ABC1 gene expression and apoA-mediated cholesterol efflux are regulated by LXR
44. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXRalpha
45. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport
46. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages
47. Plasma lipid transfer proteins
48. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice
49. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
50. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport
51. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency
52. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene
53. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver
54. Dietary cholesterol increases transcription of the human cholesteryl ester transfer protein gene in transgenic mice. Dependence on natural flanking sequences
55. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
56. Peroxisome proliferator-activated receptors, orphans with ligands and functions
57. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha
58. The orphan nuclear hormone receptor LXRalpha interacts with the peroxisome proliferator-activated receptor and inhibits peroxisome proliferator signalling
59. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta
60. Role of LXRs in control of lipogenesis